French Lucane Pharma was founded in 2009 and is part of the privately owned company Eurocept Pharmaceuticals Holding based in the Netherlands. Eurocept Pharmaceuticals Holding is the umbrella organization for the various (international) operating companies. The holding provides finance, ICT and HR services for the different companies.

To find out more about the businesses in the holding, click on the logo. You will then reach the homepage of the business in question.

2023

EMA grants a Marketing Authorisation to Pheburane® oral solution.

2020

Eurocept Pharmaceuticals Holding becomes an internationally operating organization with offices in the Netherlands, France and Turkey.

2019

Ucedane® is the first medicine containing carglumic acid being granted a Marketing Authorisation by Turkish TMMDA (TITCK).

2017

EMA grants a Marketing Authorisation to Ucedane®.

2015

Medical Council of Canada grants a Marketing Authorisation to Pheburane®.

2014

EMA grants a Marketing Authorisation to Granupas®.

2013

EMA grants a Marketing Authorisation to Pheburane® granules.

2009

Founding of Lucane Pharma, Paris by Mr. Pierre Mambrini.

Marketing medicinal products that facilitate the therapeutic relationship between care providers and patients has been the mission of Mike van Woensel since 2001 when he established Eurocept Pharmaceuticals.